The Epidemiologic Approach to the Study of Protease Inhibitors

  • Elizabeth Fontham
  • Pelayo Correa


Protease inhibitors differ from other cancer-related dietary items in that the weight of the evidence of their protective effects is based on experimental and in vitro models rather than on studies in humans. For that reason the present comments focus on how to approach the issue from an epidemiologic point of view, with the purpose of establishing whether or not there is a causal association between protease inhibitors and human cancer. The multifactorial etiology of human cancer is a generally accepted scientific proposition. Protease inhibitors, therefore, may be just one of the factors in a complex interplay of carcinogenic and anticarcinogenic influences.


Protease Inhibitor Green Leafy Vegetable Pancreatic Cancer Risk Protease Inhibitor Activity Cancer Chemopreventive Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, C. F., (ed.), Nutritive Value of American Foods in Common Units, Agriculture Handbook No. 456, U.S. Department of Agriculture, Washington, D.C.Google Scholar
  2. Armstrong, B., and Doll, R., 1975, Environmental factors and cancer incidence in different countries with special reference to dietary practices, Int. J. Cancer 15:617–631.PubMedCrossRefGoogle Scholar
  3. Carroll, K. K., Gammel, E. B., and Plunkett, E. R., 1968, Dietary fat and mammary cancer, Can. Med. Assoc. J. 23:590–594.Google Scholar
  4. Correa, P., 1981, Epidemiologic correlations between diet and cancer frequency, Cancer Res. 41:3685–3690.PubMedGoogle Scholar
  5. Drasar, G. S., and Irving, D., 1973, Environmental factors and cancer of the colon and breast, Br. J. Cancer 27:167–172.PubMedCrossRefGoogle Scholar
  6. Gregor, O., Toman, R., and Frusona, F., 1969, Gastrointestinal cancer and nutrition, Gut 10:1031–1034.PubMedCrossRefGoogle Scholar
  7. Hems, G., 1970, Epidemiologic characteristics of breast cancer in middle and late age, Br. J. Cancer 24:226–234.PubMedCrossRefGoogle Scholar
  8. Kennedy, A. R., and Little, J. B., 1981, Effects of protease inhibitors on radiation transformation in vitro, Cancer Res. 41:2103–2108.PubMedGoogle Scholar
  9. Lea, A. J., 1967, Neoplasms and environmental factors, Ann. R. Coll. Surg. Engl. 41:432–438.PubMedGoogle Scholar
  10. Madar, Z., Gertter, A., and Birk, Y., 1979, The fate of Bowman-Birk trypsin inhibitor from soybeans in the digestive tract of chicks, Comp. Biochem. Physiol. A 62:1057.CrossRefGoogle Scholar
  11. Mills, P. K., Annegers, J. F., and Phillips, R. L., 1988a, Animal product consumption and subsequent fatal breast cancer risk among Seventh Day Adventists, Am. J. Epidemiol. 127(3):440–453.Google Scholar
  12. Mills, P. K., Beeson, L., Abbey, D. E., Fraser, G. E., and Phillips, R. L., 1988b, Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists, Cancer 61:2578–2585.PubMedCrossRefGoogle Scholar
  13. Phillips, R. L., 1975, Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists, Cancer Res. 35:3513–3522.PubMedGoogle Scholar
  14. Rackis, J. J., Wolf, W. J., and Baker, E. C., 1986, Protease inhibitors in plant foods: Content and inactivation, Adv. Exp. Med. Biol. 199:299–347.PubMedCrossRefGoogle Scholar
  15. Schelp, F.-P., and Pongpaew, P., 1988, Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors—A hypothesis, J. Epidemiol. 17:287–292.CrossRefGoogle Scholar
  16. Segi, M., Kurihara, M., and Matsuyama, T., 1969, Cancer Mortality of Selected Sites in 24 Countries, No. 5 1964–65, Sendai: Japanese Department of Public Health, Tohoku University School of Medicine.Google Scholar
  17. Troll, W., and Yavelow, J., 1983, Protease inhibitors as anticarcinogens, in: Diet, Nutrition and Cancer: From Basic Research to Policy Implications (D. A. Roe, ed.), Liss, New York.Google Scholar
  18. Troll, W., Klassen, A., and Janoff, A., 1790, Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases, Science 169:1211–1213.CrossRefGoogle Scholar
  19. Troll, W., Frenkel, K., and Wiesner, R., 1984, Protease inhibitors as anticarcinogens, J. Natl. Cancer Inst. 73:1245–1250.PubMedGoogle Scholar
  20. Umezawa, K., 1972, Enzyme Inhibitors of Microbial Origin, University of Tokyo Press, Tokyo pp. 29–32.Google Scholar
  21. Watt, B. K., and Merrill, A. L., (eds.), 1975, Composition of Foods: Raw, Processed Prepared, Agriculture Handbook No. 8., U.S. Department of Agriculture, Washington, D.C.Google Scholar
  22. Weder, J. K. P., 1986, Inhibition of human proteinases by grain legumes, Adv. Exp. Med. Biol. 199:239–279.PubMedCrossRefGoogle Scholar
  23. Wynder, E. L., Kajitani, T., Dodo, H., and Takano, A., 1970, Environmental factors of cancer of the colon and rectum. II. Japanese epidemiologic data, Cancer (Philadelphia) 23:1210–1220.CrossRefGoogle Scholar
  24. Yavelow, J., Collins, M., Birch, Y., Troll, W., and Kennedy, A. R., 1985, Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray induced transformation in vitro, Proc. Natl. Acad. Sci. USA 82:5395–5399.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Elizabeth Fontham
    • 1
  • Pelayo Correa
    • 1
  1. 1.Department of PathologyLouisiana State University Medical CenterNew OrleansUSA

Personalised recommendations